Cargando…
Celastrol impairs tumor growth by modulating the CIP2A-GSK3β-MCL-1 axis in gastric cancer cells
Background/Aim: High Cancerous Inhibitor of PP2A (CIP2A) expression has been reported in solid and hematologic malignancies and is inversely associated with prognosis in Gastric Cancer, the non-small cell lung cancer, et al. CIP2A can be a drug target for the development of novel anti-gastric cancer...
Autores principales: | Wu, Jin, Ye, Feng, Xu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415568/ https://www.ncbi.nlm.nih.gov/pubmed/37470692 http://dx.doi.org/10.18632/aging.204879 |
Ejemplares similares
-
Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
por: Lee, Hyun-Woo, et al.
Publicado: (2014) -
The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors
por: Qiu, Yang, et al.
Publicado: (2023) -
Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer
por: Yu, Xinyou, et al.
Publicado: (2020) -
Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
por: Gao, Fei, et al.
Publicado: (2015) -
SOX9 promotes tumor progression through the axis BMI1-p21(CIP)
por: Aldaz, Paula, et al.
Publicado: (2020)